Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update

被引:39
|
作者
Herrmann, Jeremy L.
Abarbanell, Aaron M.
Weil, Brent R.
Wang, Yue
Wang, Meijing
Tan, Jiangning
Meldrum, Daniel R.
机构
[1] Indiana Univ, Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA
[3] Indiana Univ, Sch Med, Ctr Immunobiol, Indianapolis, IN USA
来源
ANNALS OF THORACIC SURGERY | 2009年 / 88卷 / 05期
关键词
MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; LEFT-VENTRICULAR FUNCTION; STROMAL CELLS; MONONUCLEAR-CELLS; INTRACORONARY INJECTION; SKELETAL MYOBLASTS; PERIPHERAL-BLOOD;
D O I
10.1016/j.athoracsur.2009.05.079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progenitor cell therapy is a promising treatment for ischemic heart disease. Early clinical trials of autologous bone marrow-derived progenitor cell therapy for acute and chronic myocardial ischemia showed modest functional improvements after cell delivery; however, the duration of these benefits remains unclear. Ongoing investigations continue to enhance our understanding of the mechanisms by which progenitor and stem cells function and how their survival and cardioprotective abilities can be improved. This review discusses: (1) relevant progenitor and stem cells in myocardial regenerative therapy, (2) routes of cell delivery to ischemic myocardium, (3) clinical trials investigating bone marrow-derived progenitor cell therapy for myocardial ischemia, and (4) future directions of the field. (Ann Thorac Surg 2009; 88: 1714-22) (C) 2009 by The Society of Thoracic Surgeons
引用
收藏
页码:1714 / 1722
页数:9
相关论文
共 50 条
  • [1] Stem Cell-Based Therapy for Ischemic Heart Disease
    Hsiao, Lien-Cheng
    Carr, Carolyn
    Chang, Kuan-Cheng
    Lin, Shinn-Zong
    Clarke, Kieran
    [J]. CELL TRANSPLANTATION, 2013, 22 (04) : 663 - 675
  • [2] Cell-Based Therapy for Chronic Ischemic Heart Disease-A Clinical Perspective
    Perin, Emerson C.
    Silva, Guilherme V.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2011, 29 (03) : 211 - 217
  • [3] Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
    Madonna, Rosalinda
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [4] Autologous Cell-Based Therapy for Ischemic Heart Disease: Clinical Evidence, Proposed Mechanisms of Action, and Current Limitations
    Perin, Emerson C.
    Silva, Guilherme V.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (03) : 281 - 288
  • [5] Cell-Based Therapies for Ischemic Heart Disease -"Trick and Treat"-
    Limbourg, Anne
    Limbourg, Florian
    Drexler, Helmut
    [J]. CIRCULATION JOURNAL, 2009, 73 (12) : 2179 - 2182
  • [6] Advances in cell-based therapy for structural heart disease
    Mazhari, Ramesh
    Hare, Joshua M.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2007, 49 (06) : 387 - 395
  • [7] Cellular Therapy for Ischemic Heart Disease: An Update
    Peng, Hsuan
    Abdel-Latif, Ahmed
    [J]. STEM CELLS: THERAPEUTIC APPLICATIONS, 2019, 1201 : 195 - 213
  • [8] Cell-based therapy for ischemic stroke
    Zhang, Jing
    Chopp, Michael
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1229 - 1240
  • [9] An Update on Human Stem Cell-Based Therapy in Parkinson's Disease
    Gonzalez, Clara
    Bonilla, Sonia
    Isabel Flores, Ana
    Cano, Eva
    Liste, Isabel
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2016, 11 (07) : 561 - 568
  • [10] Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives
    Patschan, D.
    Kribben, A.
    Mueller, G. A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 311 (02) : F382 - F394